0 results for 'Berger Montague'
The Big Money Behind Warren and Brown's Mass. Senate Race
An analysis by MapLight.org of campaign finance data from the Federal Election Commission traced the sources behind the more than $50 million raised by Elizabeth Warren and Senator Scott Brown in their race for a senate seat in Massachusetts.
Judge OKs Cell Pathways Settlement
A federal judge has approved the settlement of a class-action shareholder`s suit against Cell Pathways Inc. of Horsham in which the pharmaceuticals company will pay the plaintiffs $2 million in cash and 1.7 million shares of CPI common stock.Despite Reform, Shareholder Suits Still Big in Philly
Securities-fraud litigators in Philadelphia are as busy as ever despite legislation designed to make it more difficult to accuse public companies of dishonesty. The constant level of activity reflects national figures showing that the number of stock-fraud lawsuits reached a record high last year. Class-action lawyers say that instead of slowing the pace, the 1995 law has caused plaintiffs to become more selective while allowing defendants to prevent more cases from proceeding past the filing stage.Cephalon Settles Shareholder Suits For $17 Million in Cash and Stock
Cephalon Inc. has agreed to pay $17 million to settle a spate of class-action shareholder suits filed in 1996 that said top corporate officers hid the truth about the prospects of an experimental drug to treat Lou Gehrig's disease. Senior U.S. District Judge Clifford Scott Green yesterday granted preliminary approval of the settlement, clearing the way for notices of it to be published in the Wall Street Journal and mailed to potential class members.
In Major Pay-to-Delay Momentum Shift, Pennsylvania Judge Green-Lights Antitrust Class Actions and FTC Claims Against Cephalon and Generics
Publication Date: 2010-03-30 Practice Area: Industry: Court: Judge: Attorneys: For plaintiff: For defendant: Case number:
This could be a game changer, folks--and it couldn't come at a more critical moment for opponents of the deals that keep generic drugs off the market.
Billion-Dollar Judgment Is Bad Omen for J&J As States Take on Drug Marketing
Publication Date: 2012-04-16 Practice Area: Industry: Court: Judge: Attorneys: For plaintiff: For defendant: Case number:
Last week's $1.1 billion award against Johnson & Johnson's Janssen Pharmaceuticals unit was the biggest yet in a cascade of state court judgments over marketing of the anti-psychotic Risperdal. But it's not over yet: More state AGs are now jumping into the fray, and J&J's lawyers at Drinker Biddle haven't shown any inclination to settle.
Lawyers Square Off Ahead of Hearing on $7 Billion Credit Card Fee Settlement
Publication Date: 2012-11-04 Practice Area: Industry: Court: Judge: Attorneys: For plaintiff: For defendant: Case number:
Ever since Visa and MasterCard reached a $7.2 billion agreement to resolve merchant claims over credit card "swipe fees," critics have been coming out of the woodwork. Now they've formally opposed the class action settlement in court, with the objector's lawyers at Constantine Cannon warning of "serious risks" if the deal is approved.
TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Vaishali Rao, Hinshaw & Culbertson Partner 1 minute read
Resources
A Buyer's Guide to Law Firm Software
Brought to you by PracticePanther
Download Now
A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster
Brought to you by HaystackID
Download Now
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now